Questcor Pharmaceuticals Soars on Q2 Results (QCOR)

By: Benzinga
Questcor Pharmaceuticals (NASDAQ: QCOR ) released its fiscal second-quarter earnings results after the closing bell on Tuesday. The company reported both earnings per share and revenue that was ahead of Wall Street analysts' consensus estimates. In late trade, the stock was last up almost 11 percent to $57.55. Related:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.